Abstract

Emerging pharmacogenetics research may improve clinical outcomes for common complex conditions typically treated in primary care settings.

Physicians' willingness to offer genetically-tailored treatments to their patients will be critical to realizing this potential.

According to recent research, it is likely that genotypes used to tailor smoking will have pleiotropic associations with other addictions and diseases, and may have different frequencies across populations.

These additional features may pose an additional barrier to adoption.

To ...

Esta siendo redirigido al contenido completo...